FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:236-244 July 23, 1998 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

The human immunodeficiency virus (HIV) has infected nearly 900,000 persons in North America and more than 30 million worldwide.^1,2 Since the initial description of eye abnormalities in HIV-positive patients more than 15 years ago,³ numerous reports have described the spectrum and natural history of HIV-associated eye disorders, which affect 70 to 80 percent of all patients at some point during their illness.⁴ We present here the key clinical features of the most commonly encountered ocular manifestations of HIV infection, as well as the main issues in their management.

CD4+ T-Lymphocyte Count as a Predictor of Risk

For years, the CD4+ T-lymphocyte count proved a reliable predictor of the . . . [Full Text of this Article]

Adnexal Manifestations

Herpes Zoster Ophthalmicus

Kaposi's Sarcoma

Molluscum Contagiosum

Conjunctival Microvasculopathy

Anterior-Segment Manifestations

Keratoconjunctivitis Sicca

Infectious Keratitis

Iridocyclitis

Posterior-Segment Manifestations

Retinal Microvasculopathy

Infectious Retinitis

            Cytomegalovirus Retinitis

            Varicella–Zoster Virus Retinitis

            Toxoplasmic Retinochoroiditis

            Bacterial and Fungal Retinitis

Infectious Choroiditis

Orbital Manifestations

Neuro-Ophthalmic Manifestations

Ocular Manifestations in Children

Ocular Manifestations in Developing Countries

Ocular Toxicity in HIV-Infected Patients

Source Information

From the Francis I. Proctor Foundation and the Department of Ophthalmology, University of California, San Francisco, Medical Center, San Francisco.

Address reprint requests to Dr. Cunningham at the Francis I. Proctor Foundation, UCSF Medical Center, San Francisco, CA 94143-0944.

References

This article has been cited by other articles:

• Nasoodi, A, Lim, L T, Al-Ani, A, Quah, S, Dinsmore, W W (2008). What you can see in your patient's eyes? Review of ocular manifestations of HIV in HAART era. Int J STD AIDS 19: 4-11 [Abstract] [Full Text]  
• Congdon, N. G., Friedman, D. S., Lietman, T. (2003). Important Causes of Visual Impairment in the World Today. JAMA 290: 2057-2060 [Full Text]  
• Dix, R. D., Podack, E. R., Cousins, S. W. (2003). Loss of the Perforin Cytotoxic Pathway Predisposes Mice to Experimental Cytomegalovirus Retinitis. J. Virol. 77: 3402-3408 [Abstract] [Full Text]  
• Nau, J. A., Shields, C. L., Shields, J. A., Eagle, R. C., Rice, E. (2002). Acute Myeloid Leukemia Manifesting Initially as a Conjunctival Mass in a Patient With Acquired Immunodeficiency Syndrome. Arch Ophthalmol 120: 1741-1742 [Full Text]  
• Beare, N A V, Kublin, J G, Lewis, D K, Schijffelen, M J, Peters, R P H, Joaki, G, Kumwenda, J, Zijlstra, E E (2002). Ocular disease in patients with tuberculosis and HIV presenting with fever in Africa. Br J Ophthalmol 86: 1076-1079 [Abstract] [Full Text]  
• Detrick, B., Nagineni, C. N., Grillone, L. R., Anderson, K. P., Henry, S. P., Hooks, J. J. (2001). Inhibition of Human Cytomegalovirus Replication in a Human Retinal Epithelial Cell Model by Antisense Oligonucleotides. IOVS 42: 163-169 [Abstract] [Full Text]  
• CUNNINGHAM, E. T JR (2000). Uveitis in HIV positive patients. Br J Ophthalmol 84: 233-236 [Full Text]  
• MacCumber, M. W., Sadeghi, S., Cohen, J. A., Deutsch, T. A. (1999). Suture Loop to Aid in Ganciclovir Implant Removal. Arch Ophthalmol 117: 1250-1254 [Abstract] [Full Text]